GEMCITABINE

Product NDC
68001-348
11-digit product format
680010348
Labeler code
68001
Product ID
68001-348_049982fe-a321-b868-e063-6294a90ae861
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GEMCITABINE
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
BluePoint Laboratories
Application
NDA209604
Marketing category
NDA
Marketing start
2018-05-25
Substance
GEMCITABINE HYDROCHLORIDE
Active strength
100 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N209604-001GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03
N209604-002GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03
N209604-003GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03
N209604-004GEMCITABINE HYDROCHLORIDEGEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03caaa826d4ba7…
2026-08-18 06:07:402026-07N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03caaa826d4ba7…
2026-08-18 06:07:402026-07N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03caaa826d4ba7…
2026-08-18 06:07:402026-07N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD2017-08-03caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0331067a03dcf5…
2025-08-23 18:47 UTC2025-08N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-036a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-0303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-032680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-032680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-032680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-032680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-035bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-035bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-035bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-035bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209604-001GEMCITABINE HYDROCHLORIDE200MG/2ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209604-002GEMCITABINE HYDROCHLORIDE1GM/10ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209604-003GEMCITABINE HYDROCHLORIDE1.5GM/15ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209604-004GEMCITABINE HYDROCHLORIDE2GM/20ML (100MG/ML)SOLUTION / INTRAVENOUSRLD, RS2017-08-03d8e5a09893c0…

Additional Listing Data#

Finished product
Yes
Brand name base
GEMCITABINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GEMCITABINE HYDROCHLORIDE100 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
U347PV74ILInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1998783Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4031017d-d768-46de-8081-476bcb883f5eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a2b7d477-0e35-4772-8a9d-99c71e3e210bProduct name220190614
4c31c9b8-06d5-4f83-9eb7-cd946af7067aProduct name520190612
a12a1c0c-65f2-45a0-8bf0-7dfc55c750b6Product name120180829
d2980057-8cff-4896-979e-b4c394974cfdProduct name120170829

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68001-348-36GEMCITABINE10 mL in 1 VIAL, MULTI-DOSEINJECTION, SOLUTION105
68001-348-36GEMCITABINE1 in 1 CARTONINJECTION, SOLUTION15

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68001-348-36ML - Milliliter68001-3486faff9a3-4798-401c-a62e-54ef1a6bf66e12018-06-11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68001-348GEMCITABINE INJECTION, SOLUTION [BLUEPOINT LABORATORIES]5Current NDC, Legacy NDC, 2 package rows20230912_4031017d-d768-46de-8081-476bcb883f5e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GEMCITABINEGEMCITABINEBluePoint Laboratories4031017d-d768-46de-8081-476bcb883f5e2023-09-11Warnings, Adverse reactionsExact identifier
application applno (NDA): 209604
application number: NDA209604
ndc (product): 68001-348

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1998783gemcitabine 100 MG/mL Injectable SolutionPSN4031017d-d768-46de-8081-476bcb883f5e5
1998783gemcitabine 100 MG/ML Injectable SolutionSCD4031017d-d768-46de-8081-476bcb883f5e5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
68001-348-36680010348361 VIAL, MULTI-DOSE in 1 CARTON (68001-348-36) / 10 mL in 1 VIAL, MULTI-DOSE2018-05-250000-00-00NoNoCurrent